Involvement of PI3K/Akt and p38 MAPK in the induction of COX-2 expression by bacterial lipopolysaccharide in murine adrenocortical cells

Molecular and Cellular Endocrinology

Volumn 384, Issue 1-2, 2014, Pages 43-51

  Mercau, M E ^a   Astort, F ^a   Giordanino, E F ^a   Martinez Calejman, C ^a   Sanchez, R ^a   Caldareri, L ^a   Repetto, E M ^a   Coso, O A ^b   Cymeryng, C B ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

Adrenocortical cells; AKT PKB; Cyclooxygenase 2; Lipopolysaccharide; P38 MAPK

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ADRENAL CORTEX CELL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADRENOCORTICAL CELLS; AKT/PKB; CYCLOOXYGENASE-2; LIPOPOLYSACCHARIDE; P38 MAPK;

ADRENAL CORTEX; ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CHROMONES; CYCLOOXYGENASE 2; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MALE; MICE; MORPHOLINES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84893412507     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.01.007     Document Type: Article

References (60)

1. Bode J.G., Ehlting C., Haussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal 2012, 24:1185-1194. 10.1016/j.cellsig.2012.01.018 S0898-6568(12)00041-1 [pii].
2. Bornstein S.R., Ehrhart-Bornstein M., Scherbaum W.A. Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland. Microsc. Res. Tech. 1997, 36:520-533.
3. Bornstein S.R., Rutkowski H., Vrezas I. Cytokines and steroidogenesis. Mol. Cell Endocrinol. 2004, 215:135-141.
4. Chen C., Chen Y.H., Lin W.W. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 1999, 97:124-129.
5. Chin M.S., Nagineni C.N., Hooper L.C., Detrick B., Hooks J.J. Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:2338-2346.
6. Chun K.S., Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 2004, 68:1089-1100.
7. Cuenda A., Rousseau S. P38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375. S0167-4889(07)00070-5 [pii]. 10.1016/j.bbamcr.2007.03.010.
8. Cymeryng C.B., Dada L.A., Podesta E.J. Effect of nitric oxide on rat adrenal zona fasciculata steroidogenesis. J. Endocrinol. 1998, 158:197-203.
9. Cymeryng C.B., Dada L.A., Colonna C., Mendez C.F., Podesta E.J. Effects of L-arginine in rat adrenal cells: involvement of nitric oxide synthase. Endocrinology 1999, 140:2962-2967.
10. De Stefano D., Maiuri M.C., Simeon V., Grassia G., Soscia A., Cinelli M.P., Carnuccio R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur. J. Pharmacol. 2007, 566:192-199.
11. Degousee N., Martindale J., Stefanski E., Cieslak M., Lindsay T.F., Fish J.E., Marsden P.A., Thuerauf D.J., Glembotski C.C., Rubin B.B. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ. Res. 2003, 92:757-764. 10.1161/01.RES.0000067929.01404.03 01.RES.0000067929.01404.03 [pii].
12. Emre Y., Hurtaud C., Nubel T., Criscuolo F., Ricquier D., Cassard-Doulcier A.M. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. Biochem. J. 2007, 402:271-278.
13. Engstrom L., Rosen K., Angel A., Fyrberg A., Mackerlova L., Konsman J.P., Engblom D., Blomqvist A. Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland. Endocrinology 2008, 149:1436-1450.
14. Giralt M., Blanquez A., Avila J., Hidalgo J. Effect of superoxide dismutase, allopurinol and glucocorticoids on liver and lung metallothionein induction by endotoxin in the rat. Biometals 1993, 6:101-106.
15. Gorina R., Font-Nieves M., Marquez-Kisinousky L., Santalucia T., Planas A.M. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways. Glia 2011, 59:242-255. 10.1002/glia.21094.
16. Grion N., Repetto E.M., Pomeraniec Y., Calejman C.M., Astort F., Sanchez R., Pignataro O.P., Arias P., Cymeryng C.B. Induction of nitric oxide synthase and heme oxygenase activities by endotoxin in the rat adrenal cortex: involvement of both signaling systems in the modulation of ACTH-dependent steroid production. J. Endocrinol. 2007, 194:11-20.
17. Grishin A.V., Wang J., Potoka D.A., Hackam D.J., Upperman J.S., Boyle P., Zamora R., Ford H.R. Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J. Immunol. 2006, 176:580-588.
18. Haddad J.J., Land S.C. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br. J. Pharmacol. 2002, 135:520-536.
19. Hanke C.J., Drewett J.G., Myers C.R., Campbell W.B. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect. Endocrinology 1998, 139:4053-4060.
20. Hata A.N., Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 2004, 103:147-166.
21. Hemmings B.A., Restuccia D.F. PI3K-PKB/Akt pathway. Cold Spring Harb. Perspect Biol. 2012, 4:a011189. 10.1101/cshperspect.a011189 a011189 [pii] 4/9/a011189 [pii].
22. Herschman H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 1994, 13:241-256.
23. Hinz B., Brune K., Pahl A. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2000, 272:744-748.
24. Hsu H.Y., Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 2002, 277:22131-22139. 10.1074/jbc.M111883200 M111883200 [pii].
25. Huang H.L., Chiang M.F., Lin C.W., Pu H.F. Lipopolysaccharide directly stimulates aldosterone production via toll-like receptor 2 and toll-like receptor 4 related PI(3)K/Akt pathway in rat adrenal zona glomerulosa cells. J. Cell Biochem. 2010, 111:872-880. 10.1002/jcb.22774.
26. Jijon H., Allard B., Jobin C. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway. Cell Signal 2004, 16:1023-1032.
27. Jin Y., Kim H.P., Chi M., Ifedigbo E., Ryter S.W., Choi A.M. Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am. J. Respir Cell Mol. Biol. 2008, 39:171-179.
28. Kim M.H., Kim M.O., Heo J.S., Kim J.S., Han H.J. Acetylcholine inhibits long-term hypoxia-induced apoptosis by suppressing the oxidative stress-mediated MAPKs activation as well as regulation of Bcl-2, c-IAPs, and caspase-3 in mouse embryonic stem cells. Apoptosis 2008, 13:295-304.
29. Kuldo J.M., Westra J., Asgeirsdottir S.A., Kok R.J., Oosterhuis K., Rots M.G., Schouten J.P., Limburg P.C., Molema G. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 2005, 289:C1229-C1239. doi: 00620.2004 [pii] 10.1152/ajpcell.00620.2004.
30. Lai C.S., Lee J.H., Ho C.T., Liu C.B., Wang J.M., Wang Y.J., Pan M.H. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J. Agric Food Chem. 2009, 57:10990-10998.
31. Lee J.Y., Ye J., Gao Z., Youn H.S., Lee W.H., Zhao L., Sizemore N., Hwang D.H. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 2003, 278:37041-37051. 10.1074/jbc.M305213200.
32. Lee I.T., Shih R.H., Lin C.C., Chen J.T., Yang C.M. Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun. Signal 2012, 10:33. 10.1186/1478-811X-10-33.
33. Maloney C.G., Kutchera W.A., Albertine K.H., McIntyre T.M., Prescott S.M., Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immunol. 1998, 160:1402-1410.
34. Martinez Calejman C., Astort F., Di Gruccio J.M., Repetto E.M., Mercau M., Giordanino E., Sanchez R., Pignataro O., Arias P., Cymeryng C.B. Lipopolysaccharide stimulates adrenal steroidogenesis in rodent cells by a NFkappaB-dependent mechanism involving COX-2 activation. Mol. Cell Endocrinol. 2011, 337:1-6.
35. McCubrey J.A., Lahair M.M., Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal 2006, 8:1775-1789.
36. Mifflin R.C., Saada J.I., Di Mari J.F., Adegboyega P.A., Valentich J.D., Powell D.W. Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am. J. Physiol. Cell Physiol. 2002, 282:C824-C834.
37. Mohn C.E., Fernandez-Solari J., De Laurentiis A., Bornstein S.R., Ehrhart-Bornstein M., Rettori V. Adrenal gland responses to lipopolysaccharide after stress and ethanol administration in male rats. Stress 2011, 14:216-226. 10.3109/10253890.2010.532254.
38. Molina-Holgado E., Ortiz S., Molina-Holgado F., Guaza C. Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol. 2000, 131:152-159.
39. Montaner S., Sodhi A., Pece S., Mesri E.A., Gutkind J.S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res. 2001, 61:2641-2648.
40. Noble F., Rubira E., Boulanouar M., Palmier B., Plotkine M., Warnet J.M., Marchand-Leroux C., Massicot F. Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice. Neurosci. Lett. 2007, 424:106-110.
41. Nowak D., Pietras T., Antczak A., Krol M., Piasecka G. Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice. Antonie Van Leeuwenhoek 1993, 63:77-83.
42. O'Sullivan A.W., Wang J.H., Redmond H.P. The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells. J. Surg. Res. 2009, 151:138-144.
43. Pomeraniec Y., Grion N., Gadda L., Pannunzio V., Podesta E.J., Cymeryng C.B. Adrenocorticotropin induces heme oxygenase-1 expression in adrenal cells. J. Endocrinol. 2004, 180:113-124.
44. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 1996, 16:1247-1255.
45. Rajaram M.V., Ganesan L.P., Parsa K.V., Butchar J.P., Gunn J.S., Tridandapani S. Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice. J. Immunol. 2006, 177:6317-6324.
46. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 1998, 439:75-80.
47. Runchel C., Matsuzawa A., Ichijo H. Mitogen-activated protein kinases in mammalian oxidative stress responses. Antioxid. Redox Signal 2011, 15:205-218. 2010.3733. 10.1089/ars.
48. Sanchez R., Mercau M.E., Repetto E.M., Martinez Calejman C., Astort F., Perez M.N., Arias P., Cymeryng C.B. Crosstalk between nitric oxide synthases and cyclooxygenase 2 in the adrenal cortex of rats under lipopolysaccharide treatment. Endocrine 2013, 10.1007/s12020-013-0104-y.
49. Schabbauer G., Luyendyk J., Crozat K., Jiang Z., Mackman N., Bahram S., Georgel P. TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages. Mol. Immunol. 2008, 45:2790-2796. 10.1016/j.molimm.2008.02.001 S0161-5890(08)00062-X [pii].
50. Schieven G.L. The biology of p38 kinase: a central role in inflammation. Curr. Top Med. Chem. 2005, 5:921-928.
51. Schmitz M.L., Bacher S., Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci. 2001, 26:186-190.
52. Sheu M.L., Chao K.F., Sung Y.J., Lin W.W., Lin-Shiau S.Y., Liu S.H. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal 2005, 17:975-984.
53. Shi D., Xiao X., Wang J., Liu L., Chen W., Fu L., Xie F., Huang W., Deng W. Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-kappaB, c/EBPbeta, and p300 signaling. J. Pineal Res. 2012, 53:154-165. 10.1111/j.1600-079X.2012.00982.x.
54. Simon F., Fernandez R. Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J. Hypertens. 2009, 27:1202-1216. 10.1097/HJH.0b013e328329e31c.
55. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 1996, 271:33157-33160.
56. Smyth E.M., Grosser T., Wang M., Yu Y., FitzGerald G.A. Prostanoids in health and disease. J. Lipid Res. 2009, 50(Suppl.):S423-S428.
57. Torres M., Forman H.J. Redox signaling and the MAP kinase pathways. BioFactors 2003, 17:287-296.
58. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38:1654-1661. S1357-2725(06)00125-7 [pii] 10.1016/j.biocel.2006.03.021.
59. Walton K.L., Holt L., Sartor R.B. Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways. Am. J. Physiol. Gastrointest Liver Physiol. 2009, 296:G601-G611. 10.1152/ajpgi.00022.2008 00022.2008 [pii].
60. Yasumura Y., Buonassisi V., Sato G. Clonal analysis of differentiated function in animal cell cultures. I. Possible correlated maintenance of differentiated function and the diploid karyotype. Cancer Res. 1966, 26:529-535.